Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Boger

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Bioorganic & Medicinal Chemistry|February 1, 1997
Catalysis of the CC-1065 and duocarmycin DNA alkylation reaction: DNA binding induced conformational change in the agent results in activationD L Boger, R M Garbaccio
Proceedings of the National Academy of Sciences of the United States of America|April 25, 1995
CC-1065 and the duocarmycins: unraveling the keys to a new class of naturally derived DNA alkylating agentsD L Boger, D S Johnson
Bioorganic & Medicinal Chemistry|April 28, 1999
DNA binding properties of key sandramycin analogues: systematic examination of the intercalation chromophoreD L Boger, K W Saionz
Bioorganic & Medicinal Chemistry|August 1, 1997
N-methyl threonine analogues of deglycobleomycin A2: synthesis and evaluationD L Boger, S Teramoto, H Cai
Journal of the American Chemical Society|July 18, 2001
Total synthesis of fostriecin (CI-920)D L Boger, S Ichikawa, W Zhong
Bioorganic & Medicinal Chemistry|February 1, 1996
Synthesis and evaluation of deglycobleomycin A2 analogues containing a tertiary N-methyl amide and simple ester replacement for the L-histidine secondary amide: direct functional characterization of the requirement for secondary amide metal complexationD L Boger, S Teramoto, H Cai
Bioorganic & Medicinal Chemistry|June 1, 1996
Demonstration and definition of the noncovalent binding selectivity of agents related to CC-1065 by an affinity cleavage agent: noncovalent binding coincidental with alkylationD L Boger, J Zhou, H Cai
Bioorganic & Medicinal Chemistry|November 1, 1995
1,2,9,9a-Tetrahydrocyclopropa[c]benz[e]indol-4-one (CBI) analogs of CC-1065 and the duocarmycins: synthesis and evaluationD L Boger, W Yun, N Han
Bioorganic & Medicinal Chemistry Letters|July 17, 2001
Substituent effects within the DNA binding subunit of CBI analogues of the duocarmycins and CC-1065D L Boger, F Stauffer, M P Hedrick
Bioorganic & Medicinal Chemistry Letters|June 20, 2001
alpha-Keto heterocycle inhibitors of fatty acid amide hydrolase: carbonyl group modification and alpha-substitutionD L Boger, H Miyauchi, M P Hedrick
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry|February 1, 1997
Catalysis of the CC-1065 and duocarmycin DNA alkylation reaction: DNA binding induced conformational change in the agent results in activationD L Boger, R M Garbaccio
Proceedings of the National Academy of Sciences of the United States of America|April 25, 1995
CC-1065 and the duocarmycins: unraveling the keys to a new class of naturally derived DNA alkylating agentsD L Boger, D S Johnson
Bioorganic & Medicinal Chemistry|April 28, 1999
DNA binding properties of key sandramycin analogues: systematic examination of the intercalation chromophoreD L Boger, K W Saionz
Bioorganic & Medicinal Chemistry|August 1, 1997
N-methyl threonine analogues of deglycobleomycin A2: synthesis and evaluationD L Boger, S Teramoto, H Cai
Journal of the American Chemical Society|July 18, 2001
Total synthesis of fostriecin (CI-920)D L Boger, S Ichikawa, W Zhong
Bioorganic & Medicinal Chemistry|February 1, 1996
Synthesis and evaluation of deglycobleomycin A2 analogues containing a tertiary N-methyl amide and simple ester replacement for the L-histidine secondary amide: direct functional characterization of the requirement for secondary amide metal complexationD L Boger, S Teramoto, H Cai
Bioorganic & Medicinal Chemistry|June 1, 1996
Demonstration and definition of the noncovalent binding selectivity of agents related to CC-1065 by an affinity cleavage agent: noncovalent binding coincidental with alkylationD L Boger, J Zhou, H Cai
Bioorganic & Medicinal Chemistry|November 1, 1995
1,2,9,9a-Tetrahydrocyclopropa[c]benz[e]indol-4-one (CBI) analogs of CC-1065 and the duocarmycins: synthesis and evaluationD L Boger, W Yun, N Han
Bioorganic & Medicinal Chemistry Letters|July 17, 2001
Substituent effects within the DNA binding subunit of CBI analogues of the duocarmycins and CC-1065D L Boger, F Stauffer, M P Hedrick
Bioorganic & Medicinal Chemistry Letters|June 20, 2001
alpha-Keto heterocycle inhibitors of fatty acid amide hydrolase: carbonyl group modification and alpha-substitutionD L Boger, H Miyauchi, M P Hedrick
Pageof 9